Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.
2.

Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.

Schwarz S, Rechenmacher M, Filbeck T, Knuechel R, Blaszyk H, Hartmann A, Brockhoff G.

J Clin Pathol. 2008 Mar;61(3):272-7. Epub 2007 Aug 10.

PMID:
17693577
3.

Lewis(y) antigen (blood group 8, BG8) is a useful marker in the histopathological differential diagnosis of flat urothelial lesions of the urinary bladder.

Gunia S, Kakies C, May M, Koch S, Erbersdobler A.

J Clin Pathol. 2011 Aug;64(8):672-6. doi: 10.1136/jclinpath-2011-200065. Epub 2011 Apr 21.

PMID:
21512109
4.

Prognostic significance of atypical papillary urothelial hyperplasia.

Swierczynski SL, Epstein JI.

Hum Pathol. 2002 May;33(5):512-7.

PMID:
12094376
6.

Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa.

Gunia S, Kakies C, Erbersdobler A, Koch S, May M.

J Clin Pathol. 2012 Aug;65(8):715-20. doi: 10.1136/jclinpath-2011-200532. Epub 2012 May 3.

PMID:
22554964
7.

HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization.

Ching CB, Amin MB, Tubbs RR, Elson P, Platt E, Dreicer R, Fergany A, Hansel DE.

Mod Pathol. 2011 Aug;24(8):1111-9. doi: 10.1038/modpathol.2011.69. Epub 2011 Apr 22.

8.

The role of immunohistochemistry in the diagnosis of flat urothelial lesions: a study using CK20, CK5/6, P53, Cd138, and Her2/Neu.

Jung S, Wu C, Eslami Z, Tanguay S, Aprikian A, Kassouf W, Brimo F.

Ann Diagn Pathol. 2014 Feb;18(1):27-32. doi: 10.1016/j.anndiagpath.2013.10.006. Epub 2013 Oct 31.

PMID:
24321464
9.

Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.

Simonetti S, Russo R, Ciancia G, Altieri V, De Rosa G, Insabato L.

Int J Surg Pathol. 2009 Jun;17(3):198-205. doi: 10.1177/1066896909333415.

PMID:
19443884
10.

No strong association between HER-2/neu protein overexpression and gene amplification in high-grade invasive urothelial carcinomas.

Caner V, Turk NS, Duzcan F, Tufan NL, Kelten EC, Zencir S, Dodurga Y, Bagci H, Duzcan SE.

Pathol Oncol Res. 2008 Sep;14(3):261-6. doi: 10.1007/s12253-008-9027-y. Epub 2008 Apr 16.

PMID:
18415713
11.

Flat intraepithelial lesions of the urinary bladder.

Cheng L, Cheville JC, Neumann RM, Bostwick DG.

Cancer. 2000 Feb 1;88(3):625-31.

PMID:
10649257
12.

[FISH analysis in the differential diagnosis of flat urothelial lesions using tissue microarrays].

Schwarz S, Rechenmacher M, Lottner C, Brockhoff G, Hartmann A, Langer S, Knüchel R.

Verh Dtsch Ges Pathol. 2004;88:184-93. German.

PMID:
16892551
13.

p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.

Yin M, Bastacky S, Parwani AV, McHale T, Dhir R.

Hum Pathol. 2008 Apr;39(4):527-35. doi: 10.1016/j.humpath.2007.08.005. Epub 2008 Jan 30.

PMID:
18234280
14.

The pagetoid variant of bladder urothelial carcinoma in situ A clinicopathological study of 11 cases.

Lopez-Beltran A, Luque RJ, Moreno A, Bollito E, Carmona E, Montironi R.

Virchows Arch. 2002 Aug;441(2):148-53. Epub 2002 Apr 4.

PMID:
12189504
15.

[Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].

Wülfing C, von Struensee D, Bierer S, Bögemann M, Hertle L, Eltze E.

Aktuelle Urol. 2005 Sep;36(5):423-9. German.

PMID:
16163605
16.

Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.

Guo CC, Fine SW, Epstein JI.

Am J Surg Pathol. 2006 Jul;30(7):883-91.

PMID:
16819332
17.

CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa.

Palmeira C, Lameiras C, Amaro T, Lima L, Koch A, Lopes C, Oliveira PA, Santos L.

Urol Oncol. 2011 Mar-Apr;29(2):205-11. doi: 10.1016/j.urolonc.2009.07.022. Epub 2009 Oct 24.

PMID:
19854077
18.

Natural history of urothelial dysplasia of the bladder.

Cheng L, Cheville JC, Neumann RM, Bostwick DG.

Am J Surg Pathol. 1999 Apr;23(4):443-7.

PMID:
10199474
19.

Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?

Gandour-Edwards R, Lara PN Jr, Folkins AK, LaSalle JM, Beckett L, Li Y, Meyers FJ, DeVere-White R.

Cancer. 2002 Sep 1;95(5):1009-15.

20.

Upregulation of fibroblast growth factor receptor 3 and epidermal growth factor receptors, in association with Raf-1, in urothelial dysplasia and carcinoma in situ after the Chernobyl accident.

Romanenko AM, Morimura K, Kinoshita A, Wanibuchi H, Takahashi S, Zaparin WK, Vinnichenko WI, Vozianov AF, Fukushima S.

Cancer Sci. 2006 Nov;97(11):1168-74. Epub 2006 Sep 5.

Supplemental Content

Support Center